Home / Drug delivery expertise /
Dermal drug delivery
We offer comprehensive CDMO solutions and expertise in both transdermal and intradermal drug delivery technologies. Navigate obstacles, embrace opportunities and turn long-term possibilities into achievable milestones with our dermal capabilities and end-to-end services, supporting your project from concept to commercialization.
Transdermal delivery
Leveraging our rich heritage of technical, regulatory and commercial success, we offer full-service CDMO capabilities for both mono and combination transdermal product therapies. Our extensive knowledge and expertise drive innovation in transdermal delivery, amplifying your product’s impact and helping you fast-track healthier tomorrows.
Explore our exceptional-by-design transdermal capabilities:
- Single-layer drug-in-adhesive patches
- Multi-layer drug-in-adhesive patches
- Active gel patch formulations (applied as a gel, dries to a discreet waterproof film)
- Customizable patch design and geometries
- Medical- and pharmaceutical-grade coatings
- Topical tapes
Intradermal delivery: Microneedle array patches
Our microneedle array patches are designed for exceptional intradermal delivery of small and large molecules, including vaccines, peptides, proteins and biologics. Microneedle array patches can offer significant benefits for healthcare systems, patients and caregivers and pharmaceutical manufacturers.
- Enhanced efficacy through improved pharmacokinetics and immunogenicity
- Faster onset of action
- Improved patient compliance and adherence
- Elimination of cold-chain storage, increasing vaccine access for underserved populations
- Preferred administration experience
- Convenient at-home dosing
- Ease of use
- Reduced impact of needle phobia
- Dose sparing
- Market expansion through self-administration
- Reduced cost of goods and distribution costs
- Life cycle extension
- Differentiation by route of administration and device/product
Solid intradermal drug-delivery platform
An array of solid-coated microneedles allows for simple and intuitive administration into the skin while providing consistent and accurate drug delivery.
Liquid delivery platform
Hollow microneedles penetrate the skin and provide a sterile fluid path for delivering your drug intradermally.
Patch applicators
While our adhesive patches are designed for easy application, achieving optimal penetration requires a standard approach to adhering the patch to the patient’s skin. Our applicators enable proper insertion, helping ensure patients receive an accurate dose.
Woodbury, MN
- 140,000 sq. ft. (13,006 m2) research, formulation and development facility
- cGMP clinical manufacturing space — cleanroom facilities with 7 process rooms
- Phase I intradermal manufacturing
Northridge, CA
- 286,000 sq. ft. (~26,570 m2) facility
- Scale-up and commercial manufacturing of transdermal products
- Transdermal coating, converting and packaging
Dermal delivery resources and insights
Explore our library of resources to learn more about our dermal drug delivery capabilities and expertise.
Transdermal CDMO capabilities
Partner with the only CDMO with multiple options to deliver drugs to and through the skin. Our end-to-end services for transdermal platforms accelerate your path to market. Download our information sheet to explore: Our 50+ years of transdermal innovation, including the first drug-in adhesive patch in 1970 An overview of our formulation, development, manufacturing, and […]
Learn More
Explore our intradermal delivery capabilities
Our intradermal delivery platforms ensure effective administration of small and large molecules, including vaccines, peptides, proteins, and biologics. With fully integrated capabilities and unrivaled experience in injectable combination products, Kindeva delivers unmatched microneedle array patch (MAP) capabilities. Download our information sheet to discover: The far-reaching potential benefits of microneedle array patch technology across clinical, environmental, […]
Learn More
Microneedle array patch characterization presentation
Microneedle array patches (MAPs) are a transformative innovation in drug delivery, with the potential to redefine how medications and vaccines reach patients. MAPs promise a simpler, more effective way to deliver a wide range of therapeutics, but their journey from concept to commercialization is filled with critical challenges. From scaling manufacturing to ensuring regulatory compliance, […]
Learn More Microneedle array patch characterization recording
Microneedle array patches (MAPs) have the potential to transform delivery of medications and vaccines. While this innovative drug delivery format could result in improved efficiency across a wide range of therapeutics, it also brings critical challenges. To successfully move from concept to commercialization, MAP manufacturers must consider scalability, regulatory compliance, and other complexities. In this […]
Learn MoreLet’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.